GW Pharmaceuticals PLC Posting of Shareholder Circular (2213N)
2016年10月22日 - 12:37AM
RNSを含む英国規制内ニュース (英語)
TIDMGWP
RNS Number : 2213N
GW Pharmaceuticals PLC
21 October 2016
GW Pharmaceuticals plc
Posting of Shareholder Circular
London, UK, 21 October 2016: GW Pharmaceuticals plc (Nasdaq:
GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company
focused on discovering, developing and commercializing novel
therapeutics from its proprietary cannabinoid product platform,
confirms that further to the announcement made on 19 October, a
circular has been published and has been posted to shareholders in
relation to the Company's intention to cancel the admission of its
0.1 pence ordinary shares to trading on AIM on 5 December,
2016.
A copy of the Circular is available on the Company's website at
the following URL: http://www.gwpharm.com.
Enquiries:
GW Pharmaceuticals plc
Stephen Schultz, VP Investor 917 280 2424 / 401 500
Relations (U.S.) 6570
FTI Consulting (Media Enquiries)
Ben Atwell / Simon Conway +44 20 3727 1000
Peel Hunt LLP (UK NOMAD)
James Steel +44 20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
CIREASEFADDKFFF
(END) Dow Jones Newswires
October 21, 2016 11:37 ET (15:37 GMT)
Gw Pharmaceuticals (LSE:GWP)
過去 株価チャート
から 5 2024 まで 6 2024
Gw Pharmaceuticals (LSE:GWP)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about GW Pharm. (ロンドン証券取引所): 0 recent articles
その他のGW Pharm.ニュース記事